Researchers have designed a non-invasive and inexpensive chip-based optical biosensor with increased sensitivity to detect the presence and progression of cancerous tumors. The cancer protein biomarker S100A4 was detected at concentrations of 300 picomolar in a synthetic urine sample.
Researchers based at the University of Toronto (ON, CA) have developed a microfluidic device that could be used to separate malignant plasma cells from healthy red blood cells. The device could have the potential to detect and monitor blood cancer.
A new study from the University of Texas at Austin (TX, USA) reports a desorption electrospray ionization mass spectrometry-based technique that could improve clinical thyroid cancer diagnosis.
A novel artificial intelligence and biosensor device has been developed to monitor if live cancer cells remain after chemotherapy treatment.
In this interview, Stephanie Traub (Cancer Research UK; London, UK) discusses her work as a biomarker specialist and the challenges she faces when developing biomarker strategies.
An isobaric labeling technique has been developed to amplify signals for comprehensive quantitative phosphoproteomic characterization of small cells populations.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
Researchers have discovered a difference between radiation-sensitive and radiation-resistant tumors that could be utilized to assess tumor response, potentially sparing some patients of the toxic side effects of ineffective radiation therapy.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.